| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Sophia Lionaki | Q59193494 |
| P2093 | author name string | John N Boletis | |
| George Liapis | |||
| P2860 | cites work | Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury | Q21195041 |
| Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group | Q21195082 | ||
| Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies | Q26784238 | ||
| Treatment of primary FSGS in adults | Q26828859 | ||
| Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | Q29617192 | ||
| World incidence of AKI: a meta-analysis | Q30410807 | ||
| Improving Outcomes from Acute Kidney Injury | Q61661823 | ||
| North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the Problem with the RIFLE Criteria | Q61661927 | ||
| Acute renal failure associated to paroxysmal nocturnal haemoglobinuria leads to intratubular haemosiderin accumulation and CD163 expression | Q63684378 | ||
| Salt-poor Human Albumin in Management of Nephrotic Syndrome | Q64913192 | ||
| IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis | Q67041224 | ||
| Renal vein thrombosis and the nephrotic syndrome | Q67601621 | ||
| Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein | Q68019131 | ||
| Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model | Q68252947 | ||
| Extrarenal complications of the nephrotic syndrome | Q68472111 | ||
| Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network | Q68574270 | ||
| Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome | Q68877409 | ||
| Pharmacokinetics and nephrotoxicity of cyclosporine in renal transplant recipients | Q69906829 | ||
| Acute Kidney Injury Recovery Pattern and Subsequent Risk of CKD: An Analysis of Veterans Health Administration Data. | Q31033237 | ||
| New insights into lipid metabolism in the nephrotic syndrome. | Q33690910 | ||
| Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. | Q33692552 | ||
| A study of the mechanisms of edema formation in patients with the nephrotic syndrome | Q33768678 | ||
| Structural basis for reduced glomerular filtration capacity in nephrotic humans | Q34185156 | ||
| The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review | Q34381902 | ||
| Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants | Q34499836 | ||
| Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis | Q34571335 | ||
| Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum | Q34643324 | ||
| The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients | Q34656118 | ||
| Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis | Q34862061 | ||
| Pathobiochemistry of nephrotic syndrome | Q35079070 | ||
| Collapsing glomerulopathy | Q35110874 | ||
| Minimal-change disease in adolescents and adults: epidemiology and therapeutic response. | Q35626525 | ||
| The severity of acute kidney injury predicts progression to chronic kidney disease | Q35669299 | ||
| Venous thromboembolism in patients with membranous nephropathy | Q35692422 | ||
| Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation | Q35758292 | ||
| Reversible renal failure in the nephrotic syndrome | Q35946476 | ||
| Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus | Q35985935 | ||
| Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management | Q36180173 | ||
| Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors | Q36322955 | ||
| AKI in Children Hospitalized with Nephrotic Syndrome | Q36349462 | ||
| A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy | Q36460769 | ||
| Cyclosporine-A-induced nephrotoxicity in children with minimal-change nephrotic syndrome: long-term treatment up to 10 years | Q36484802 | ||
| Simultaneous anti-glomerular basement membrane and membranous glomerulonephritis: case report and literature review | Q36624890 | ||
| Association of histologic variants in FSGS clinical trial with presenting features and outcomes | Q36652814 | ||
| Adult minimal-change disease: clinical characteristics, treatment, and outcomes. | Q36910586 | ||
| Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate | Q36911036 | ||
| Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. | Q37087861 | ||
| Epidemiology of acute kidney injury: how big is the problem? | Q37125697 | ||
| Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery | Q37179571 | ||
| Renal biopsy in the very elderly | Q37211053 | ||
| Value of Kidney Disease Improving Global Outcomes Urine Output Criteria in Critically Ill Patients: A Secondary Analysis of a Multicenter Prospective Cohort Study | Q37228482 | ||
| Regional variation in the incidence of dialysis-requiring AKI in the United States | Q37247010 | ||
| A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. | Q50549660 | ||
| High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. | Q51111868 | ||
| NSAID use and progression of chronic kidney disease. | Q51762640 | ||
| Acute kidney injury: a problem of definition. | Q53471884 | ||
| Study of proteins and fibrinolysis in patients with glomerulonephritis. | Q54257254 | ||
| Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. | Q54420157 | ||
| Adult-onset minimal change nephrotic syndrome: a long-term follow-up. | Q54426712 | ||
| Are Outcomes from Severe Acute Kidney Injury Really Improving? | Q54741935 | ||
| Adult minimal-change disease: observational data from a UK centre on patient characteristics, therapies, and outcomes | Q56888597 | ||
| Thrombosis and hemostasis in renal disease | Q57791595 | ||
| Hemostatic problems and thromboembolic complications in nephrotic children | Q57816651 | ||
| Practical aspects in the use of cyclosporin in paediatric nephrology | Q37359158 | ||
| Nonsteroidal antiinflammatory drugs--differences and similarities | Q37719404 | ||
| Cellular and molecular mechanisms of cyclosporin nephrotoxicity | Q37806093 | ||
| Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals | Q37920044 | ||
| Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). | Q37920869 | ||
| Focal segmental glomerulosclerosis | Q37970393 | ||
| Chronic kidney disease following acute kidney injury-risk and outcomes | Q38068098 | ||
| KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury. | Q38090134 | ||
| International Society of Nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): a human rights case for nephrology | Q38380455 | ||
| Cyclosporine | Q38733507 | ||
| Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. | Q39573370 | ||
| Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy | Q39644050 | ||
| Acute kidney injury, mortality, length of stay, and costs in hospitalized patients | Q39730814 | ||
| Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome | Q39835409 | ||
| The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases | Q40007499 | ||
| Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease | Q40369592 | ||
| The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series | Q40380232 | ||
| Renal vein thrombosis treated with thrombolytic therapy: case report and brief review | Q40523574 | ||
| Effect of lipids on glomerular injury and progression of renal disease. | Q40682135 | ||
| Nonrenal complications of the nephrotic syndrome | Q40759620 | ||
| Renal vein thrombosis in nephrotic syndrome--a prospective study of 54 cases | Q40776116 | ||
| Thromboembolic risks and complications in nephrotic children | Q40911978 | ||
| Clinical spectrum and complications of the nephrotic syndrome | Q41472878 | ||
| 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy | Q41551449 | ||
| Foot process fusion and glomerular filtration rate in minimal change nephrotic syndrome | Q41577381 | ||
| Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study | Q41596673 | ||
| ARF in children with minimal change nephrotic syndrome may be related to functional changes of the glomerular basal membrane | Q42457586 | ||
| Reversible elevations of serum creatinine levels but no effect on glomerular filtration during treatment with the direct thrombin inhibitor AZD0837. | Q43036231 | ||
| Observations on edema formation in the nephrotic syndrome in adults with minimal lesions | Q44383325 | ||
| Molecular mechanisms of lipid disorders in nephrotic syndrome | Q44390544 | ||
| Albumin regulates the Na+/H+ exchanger 3 in OKP cells | Q44669189 | ||
| An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy | Q44813351 | ||
| The prognosis of renal vein thrombosis: a re-evaluation of 27 cases | Q45002528 | ||
| Long-term prognosis after acute kidney injury requiring renal replacement therapy | Q45346350 | ||
| Warfarin-related nephropathy is the tip of the iceberg: direct thrombin inhibitor dabigatran induces glomerular hemorrhage with acute kidney injury in rats | Q45835915 | ||
| Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. | Q45940047 | ||
| Possible genetic predisposition to idiopathic focal segmental glomerulosclerosis | Q46244078 | ||
| Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure | Q46463519 | ||
| Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression | Q46906576 | ||
| Successful outpatient treatment of renal vein thrombosis by low-molecular weight heparins in 3 patients with nephrotic syndrome. | Q47332624 | ||
| Health Care Costs Associated with AKI. | Q50099458 | ||
| Clinicopathological study of nephrotic syndrome in childhood | Q70138834 | ||
| Nephrotic syndrome | Q70594857 | ||
| Clinical course and renal function in minimal change nephrotic syndrome | Q70635137 | ||
| Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate | Q70829847 | ||
| Streptokinase salvage of renal function after renal vein thrombosis | Q71254766 | ||
| Identification of circulating immune complexes in a subpopulation of patients with membranous glomerulonephropathy | Q71294721 | ||
| The clinical spectrum of renal vein thrombosis: acute and chronic | Q71424497 | ||
| Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment | Q71454048 | ||
| Hageman factor deposition in membranous glomerulopathy | Q71466913 | ||
| An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group | Q71700433 | ||
| Renal vein thrombosis in idiopathic membranous glomerulopathy and nephrotic syndrome: incidence and significance | Q71712905 | ||
| Redox cycling of human methaemoglobin by H2O2 yields persistent ferryl iron and protein based radicals | Q71713564 | ||
| Nephrotic syndrome. A hypercoagulable state | Q71845234 | ||
| Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis | Q72154567 | ||
| Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies | Q72314573 | ||
| Effect of cyclosporin A on glomerular filtration rate in children with minimal change nephrotic syndrome | Q72771728 | ||
| Oliguric renal failure in the nephrotic syndrome | Q72781746 | ||
| Pathogenesis of edema formation in the nephrotic syndrome | Q73150145 | ||
| Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome | Q73338484 | ||
| Pathophysiology of acute renal failure in idiopatic nephrotic syndrome | Q73398081 | ||
| Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis | Q73487103 | ||
| Vascular hyperpermeability in nephrotic edema | Q73925564 | ||
| Clinical aspects of renal vein thrombosis | Q74224074 | ||
| Renal vein thrombosis and the nephrotic syndrome with complete remission | Q76489196 | ||
| Cellular mechanisms of vascular injury mediated by calcineurin inhibitors | Q80366151 | ||
| Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art | Q80404735 | ||
| Bilateral renal infarctions and lower limbs artery thrombosis in a patient with nephrotic syndrome | Q80416322 | ||
| Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome | Q80447428 | ||
| Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes | Q80477531 | ||
| Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis | Q80507400 | ||
| Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors | Q82087278 | ||
| Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis | Q84945039 | ||
| Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation | Q89296972 | ||
| Acute kidney injury complicating nephrotic syndrome of minimal change disease | Q89447782 | ||
| Acute kidney injury in patients with nephrotic syndrome undergoing contrast-enhanced CT for suspected venous thromboembolism: a propensity score-matched retrospective cohort study | Q89815922 | ||
| Proteasuria-The impact of active urinary proteases on sodium retention in nephrotic syndrome | Q90828762 | ||
| Recurrent venous thromboembolism in primary membranous nephropathy despite direct Xa inhibitor therapy | Q93023168 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P921 | main subject | kidney | Q9377 |
| acute kidney injury | Q424337 | ||
| nephrotic syndrome | Q504790 | ||
| P577 | publication date | 2019-07-11 | |
| P1433 | published in | Medicina | Q26842055 |
| P1476 | title | Pathogenesis and Management of Acute Kidney Injury in Patients with Nephrotic Syndrome Due to Primary Glomerulopathies | |
| P478 | volume | 55 |
| Q89805119 | TLR2 Expression on Select Lymphocyte Subsets as a New Marker in Glomerulonephritis | cites work | P2860 |
Search more.